In vivo models reveal that stromal cells, not tumor cells, are major sources of IGFs, with non-immune stromal cells and tumor-associated macrophages (TAMs) expressing Igf1 and Igf2 mRNA [134]. Here, IGF2 is linked to neoplasm.